Seminars in Nuclear Medicine

Papers
(The TQCC of Seminars in Nuclear Medicine is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Theranostics in Lung Neuroendocrine Tumors168
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques126
Letter from the Editors79
PET/CT in the Imaging of CNS Tumors74
New targets of PET imaging for renal cancer65
The Value of FDG PET/CT in Penile Cancer: An Update59
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update57
Non-FDG hypoxia tracers57
FAPI-PET in Cardiovascular Disease46
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies46
New Promising Targets for Imaging in Cardiovascular Diseases45
Imaging of Invasive Fungal Infections- The Role of PET/CT44
Autoimmune Thyroid Diseases43
Sentinel Lymph Node Methods in Breast Cancer43
Artificial Intelligence for Drug Discovery: An Update and Future Prospects40
Letter from the Editors40
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer39
Imaging for Radiation Planning in Breast Cancer39
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled39
The Role of Nuclear Medicine in Benign Thyroid Disease39
Prognostic Value of PSMA PET/CT in Prostate Cancer38
Molecular Imaging in Inflammatory Bowel Disease37
CD70-Targeted Radiotheranostics: Now and Future37
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy37
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects35
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity33
Global experience in brain amyloid imaging33
Total-Body PET/CT: A Role of Artificial Intelligence?33
The Evolution of Artificial Intelligence in Nuclear Medicine32
PET-CT radiomics for immunotherapy response31
New Approaches for Imaging Bacteria30
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma30
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis29
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-1929
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects27
Expanding Role for Gallium-68 PET Imaging in Oncology25
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects25
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I25
18F-Fluoride PET/CT—Updates25
PET/MR Technology: Advancement and Challenges25
Use of Radionuclide-Based Imaging Methods in Breast Cancer24
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology24
Renography: Methods and Pitfalls23
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices23
Update on Pediatric Nuclear Medicine in Acute Care23
Letter From the Editors23
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma21
Total-body PET/CT – First Clinical Experiences and Future Perspectives21
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine21
FDG PET/CT for Staging Lung Carcinoma: An Update20
Standardized PSMA-PET Imaging of Advanced Prostate Cancer20
Nuclear Medicine Preclinical Research: The Role of Cell Cultures20
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases20
Impact of COVID-19 on Nuclear Medicine in Asia19
Therapy strategies to defeat prostate cancer heterogeneity19
Radiolabeled Somatostatin Analogs for Cancer Imaging19
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview19
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review19
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging19
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?19
Artificial Intelligence Augmented Cerebral Nuclear Imaging18
Targeted Radiopharmaceutical Therapy for Bone Metastases18
Functional Imaging of Testicular Torsion18
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment18
Safe Pulmonary Scintigraphy in the Era of COVID-1918
The Clinical Utility of Molecular Imaging in COVID-19: An Update18
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends17
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine17
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET16
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?16
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls16
Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature16
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma16
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace16
Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma16
Artificial Intelligence and Workforce Diversity in Nuclear Medicine16
The Impact of COVID-19 on Nuclear Medicine in Europe16
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy15
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-515
A Role of Non-FDG Tracers in Lung Cancer?15
Letter from the Editors15
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)15
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma15
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case15
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides14
Letter From the Editors14
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence14
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System14
FDG-PET/CT of COVID-19 and Other Lung Infections14
RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine14
Neuroimaging of Mild Traumatic Injury14
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors14
Prostate Cancer Theranostics With 177Lu-PSMA14
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?14
Letter From the Guest Editors14
0.042989015579224